Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seminars in hematology

Showing results (1-10 of 2,736) with videos related to

Pageof 274
Sort By:
Seminars in Hematology|August 30, 2001
The role of Bcr-Abl in chronic myeloid leukemia and stem cell biologyO Witte
Seminars in Hematology|August 30, 2001
Molecular studies in chronic myeloid leukemia patients treated with tyrosine kinase inhibitorsC L Sawyers
Seminars in Hematology|August 30, 2001
Interferon-alfa-based treatment of chronic myeloid leukemia and implications of signal transduction inhibitionM Talpaz
Seminars in Hematology|August 30, 2001
Perspectives on the future of chronic myeloid leukemia treatmentF R Appelbaum
Seminars in Hematology|August 7, 2001
Randomized trial experience of the Intergroupe Francophone du MyélomeM Attal, J L Harousseau
Seminars in Hematology|July 19, 2002
Direct thrombin inhibitorsKaren L Kaplan, Charles W Francis
Seminars in Hematology|July 19, 2002
Towards safer thrombolytic therapyVictor J Marder, Daphne Stewart
Seminars in Hematology|November 26, 2002
Monoclonal antibody therapies in leukemiasMartin S Tallman
Seminars in Hematology|October 17, 2002
African iron overloadVictor R Gordeuk
Seminars in Hematology|October 17, 2002
The copper-iron connection: hereditary aceruloplasminemiaThalia Nittis, Jonathan D Gitlin
Pageof 274

Showing results (1-10 of 2,736) with videos related to

Sort By:
Pageof 274
Seminars in Hematology|August 30, 2001
The role of Bcr-Abl in chronic myeloid leukemia and stem cell biologyO Witte
Seminars in Hematology|August 30, 2001
Molecular studies in chronic myeloid leukemia patients treated with tyrosine kinase inhibitorsC L Sawyers
Seminars in Hematology|August 30, 2001
Interferon-alfa-based treatment of chronic myeloid leukemia and implications of signal transduction inhibitionM Talpaz
Seminars in Hematology|August 30, 2001
Perspectives on the future of chronic myeloid leukemia treatmentF R Appelbaum
Seminars in Hematology|August 7, 2001
Randomized trial experience of the Intergroupe Francophone du MyélomeM Attal, J L Harousseau
Seminars in Hematology|July 19, 2002
Direct thrombin inhibitorsKaren L Kaplan, Charles W Francis
Seminars in Hematology|July 19, 2002
Towards safer thrombolytic therapyVictor J Marder, Daphne Stewart
Seminars in Hematology|November 26, 2002
Monoclonal antibody therapies in leukemiasMartin S Tallman
Seminars in Hematology|October 17, 2002
African iron overloadVictor R Gordeuk
Seminars in Hematology|October 17, 2002
The copper-iron connection: hereditary aceruloplasminemiaThalia Nittis, Jonathan D Gitlin
Pageof 274